Search

Author/Creator Mahner, Sven

1. 2022-RA-1725-ESGO Pazopanib with Topotecan weekly for patients with platinum-resistant or intermediate-sensitive recurrent ovarian cancer- results of a multicentre NOGGO phase I and II study (TOPAZ). (20th October 2022)

Authors:
Arndt, Tjadina; Chekerov, Radoslav; Pietzner, Klaus; Yalcinkaya, Isil; Canzler, Ulrich; Wimberger, Pauline; Strauß, Hans Georg; Mahner, Sven; Woelber, Linn; de Gregorio, Nikolaus; Hacker, Ulrich Thorsten; Abel, Ekkehard von; Richter, Rolf; Sehouli, Jalid
Journal:
International journal of gynecological cancer
Issue:
Volume 32(2022)Supplement 2
Page Start:
A364
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗

2. 2022-RA-285-ESGO Real world data of treatment and outcome of patients with early ovarian cancer (FIGO I) in Germany (QS Ovar of the AGO Study Group). (20th October 2022)

Authors:
Sehouli, Jalid; Bois, Andreas du; Pfisterer, Jacobus; Hilpert, Felix; Kerkmann, Markus; Mahner, Sven; de Gregorio, Nikolaus; Hanker, Lars Ch; Heitz, Florian; Marmé, Frederik; Wölber, Linn Lena; Holtmann, Laura; Polleis, Sandra; Wimberger, Pauline; Harter, Philipp; Study Group, AGO
Journal:
International journal of gynecological cancer
Issue:
Volume 32(2022)Supplement 2
Page Start:
A228
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗

3. 2022-RA-420-ESGO Treatment and outcome of patients with high-grade advanced ovarian cancer (AOC) – real world data of the german quality assurance project (QS Ovar of the AGO Study Group). (20th October 2022)

Authors:
Mahner, Sven; Bois, Andreas du; Pfisterer, Jacobus; Hilpert, Felix; Kerkmann, Markus; Sehouli, Jalid; de Gregorio, Nikolaus; Hanker, Lars Ch; Heitz, Florian; Marmé, Frederik; Wölber, Linn Lena; Holtmann, Laura; Elser, Gabriele; Harter, Philipp; Study Group, AGO
Journal:
International journal of gynecological cancer
Issue:
Volume 32(2022)Supplement 2
Page Start:
A230
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗

4. 2022-RA-798-ESGO Diagnosis of first relapse and its impact on quality of life in patients with advanced ovarian cancer (AGO-OVAR 19/II). (20th October 2022)

Authors:
Harter, Philipp; Ataseven, Beyhan; Burges, Alexander; Reuss, Alexander; Kommoss, Stefan; Sehouli, Jalid; Lampe, Björn; Schmalfeldt, Barbara; Wimberger, Pauline; Witteler, Ralf; Buderath, Paul; Herwig, Uwe; Bronger, Holger; Emons, Günter; Klar, Maximilian; Hasenburg, Annette; de Gregorio, Nikolaus...
Journal:
International journal of gynecological cancer
Issue:
Volume 32(2022)Supplement 2
Page Start:
A263
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗

5. 2022-RA-835-ESGO AGO-OVAR 2.34/MIROVA: A randomized phase II trial of Mirvetuximab soravtansine (IMGN853), in folate receptor alpha (FRα) high recurrent ovarian cancer eligible for platinum-based chemotherapy. (20th October 2022)

Authors:
Trillsch, Fabian; Schochter, Fabienne; Park-Simon, Tjoung-Won; Reuß, Alexander; Fehm, Tanja; Wimberger, Pauline; Bronger, Holger; Schmalfeldt, Barbara; Sehouli, Jalid; Marmé, Frederik; Heitz, Florian; Mahner, Sven; Fredrich, Michaela; Barth, Stefanie; Stec, James; Method, Michael; Harter, Philipp
Journal:
International journal of gynecological cancer
Issue:
Volume 32(2022)Supplement 2
Page Start:
A268
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗

6. A combination of immunohistochemical markers, MUC1, MUC5AC, PAX8 and growth pattern for characterization of mucinous neoplasm of the ovary. Issue 5 (19th February 2022)

Authors:
Chelariu-Raicu, Anca; Holley, Eva; Mayr, Doris; Klauschen, Frederick; Wehweck, Fabienne; Rottmann, Miriam; Kessler, Mirjana; Kaltofen, Till; Czogalla, Bastian; Trillsch, Fabian; Mahner, Sven; Schmoeckel, Elisa
Journal:
International journal of gynecological cancer
Issue:
Volume 32:Issue 5(2022)
Page Start:
662
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗

7. Adjuvant Therapies for Breast Cancer Improve Cure Rates but Appear to Shorten Post-Metastatic Survival. (November 2017)

Authors:
Harbeck, Nadia; Hölzel, Dieter; Eckel, Renate; Bauerfeind, Ingo; Baier, Bernd; Beck, Thomas; Braun, Michael; Ettl, Johannes; Hamann, Ulrich; Kiechle, Marion; Mahner, Sven; Schindlbeck, Christian; de Waal, Johann; Engel, Jutta
Journal:
Breast
Issue:
Volume 36(2017)
Page Start:
S74
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗

9. AID/APOBEC-network reconstruction identifies pathways associated with survival in ovarian cancer. (December 2016)

Authors:
Svoboda, Martin; Meshcheryakova, Anastasia; Heinze, Georg; Jaritz, Markus; Pils, Dietmar; Castillo-Tong, Dan; Hager, Gudrun; Thalhammer, Theresia; Jensen-Jarolim, Erika; Birner, Peter; Braicu, Ioana; Sehouli, Jalid; Lambrechts, Sandrina; Vergote, Ignace; Mahner, Sven; Zimmermann, Philip; Zeilling...
Journal:
BMC genomics
Issue:
Volume 17:Number 1(2016)
Page Start:
1
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗

10. Alopecia as surrogate marker for chemotherapy response in patients with primary epithelial ovarian cancer: A metaanalysis of four prospective randomised phase III trials with 5114 patients. Issue 7 (May 2015)

Authors:
Sehouli, Jalid; Fotopoulou, Christina; Erol, Edibe; Richter, Rolf; Reuss, Alexander; Mahner, Sven; Lauraine, Eric Pujade; Kristensen, Gunnar; Herrstedt, Jörn; du Bois, Andreas; Pfisterer, Jacobus
Journal:
European journal of cancer
Issue:
Volume 51:Issue 7(2015:May)
Page Start:
825
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗